NEONATAL MANIFESTATION OF UREA CYCLE DISORDER


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Urea cycle disorders are a group of congenital metabolic disorders at high risk of death, the pathogenesis of their pathological changes is associated with the accumulation of ammonia and other intermediate products of protein metabolism, which have a neurotoxic effect. Description. The paper presents a clinical case of a baby with the neonatal manifestation of ornithine transcarbamylase deficiency, a disease from a group of urea cycle disorders. Two previous infants (boys) in the family died at the age of 4 and 7 days of life, respectively. Both babies were born at term in satisfactory condition with normal weight and height. In both cases, the disease developed in the same way. Their condition deteriorated on day 2 of life, and there were signs of central nervous system depression, as well as respiratory distress, followed by the gradual development of convulsive disorder and coma, the genesis of which remained unclarified. By taking into account this fact, this disease was suspected during the third pregnancy and confirmed after the birth of the baby. Conclusion. The use of a protein-free diet during the first 13 days of life, then a gradual transfer to a low-protein diet, by monitoring the blood levels of ammonia and the blood amino acid spectrum, and the administration of ammonia-binding drugs could prevent brain damage and keep the baby’s life.

Full Text

Restricted Access

About the authors

A. V DEGTYAREVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: annadim@yahoo.com

E. N BAIBARINA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: baibarina@oparina4.ru

N. V EVTEYEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: NEvteeva@oparina4.ru

E. V BEREGOVAYA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology

Email: e_beregovaya@oparina4.ru

E. YU ZAKHAROVA

Medical Genetics Research Center, Russian Academy of Medical Sciences, Moscow

Email: labnbo@yandex.ru

G. V BAIDAKOVA

Medical Genetics Research Center, Russian Academy of Medical Sciences, Moscow

Email: gb2003@yandex.ru

References

  1. Hoffmann G. F., Zschocke J., Nyhan W. L., eds. Inherited metabolic diseases. Berlin; Heidelberg: Springer-Verlag; 2010.
  2. Saudubray J.-M., van den Berghe G., Walter J.H., eds. Inborn metabolic diseases. 5-th ed. Berlin; Heidelberg: Springer-Verlag; 2012: 298-309.
  3. Seminara J., Tuchman M., Krivitzky L., Krischer J., Lee H.S., Lemons C. et al. Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium. Mol. Genet. Metab. 2010; 100 (Suppl. 1): S97-105.
  4. Nassogne M.C., Héron B., Touati G., RabierD., Saudubray J.M. Urea cycle defects: management and outcome. J. Inherit. Metab. Dis. 2008; (3): 407-14.
  5. Horslen S.P., McCowan T.C., Goertzen T.C., Warkentin P.I., Cai H.B., Strom S.C., Fox I.J. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics. 2003; 111(6, Pt1): 1262-7.
  6. Najimi M., Sokal E. Update on liver cell transplantation. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 311-9.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies